Other

Investments Fair Value Disclosure

Roivant Sciences Investments Fair Value Disclosure decreased by 6.0% to $407.99M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 34.7%, from $302.94M to $407.99M. Over 5 years (FY 2020 to FY 2025), Investments Fair Value Disclosure shows an upward trend with a 16.6% CAGR.

Analysis

StatementBalance Sheet Statement
SectionOther
First reportedQ4 2025
Last reportedQ1 2026
Metric ID: other_investments_fair_value_disclosure

Historical Data

20 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$180.36M$436.78M$398.74M$325.83M$301.29M$246.61M$272.47M$304.32M$296.24M$250.39M$239.93M$247.75M$262.98M$311.35M$290.04M$302.94M$283.81M$412.32M$433.91M$407.99M
QoQ Change+142.2%-8.7%-18.3%-7.5%-18.1%+10.5%+11.7%-2.7%-15.5%-4.2%+3.3%+6.1%+18.4%-6.8%+4.4%-6.3%+45.3%+5.2%-6.0%
YoY Change+67.0%-43.5%-31.7%-6.6%-1.7%+1.5%-11.9%-18.6%-11.2%+24.3%+20.9%+22.3%+7.9%+32.4%+49.6%+34.7%
Range$180.36M$436.78M
CAGR+18.7%
Avg YoY Growth+8.5%
Median YoY Growth+4.7%

Investments Fair Value Disclosure at Other Companies

Frequently Asked Questions

What is Roivant Sciences's investments fair value disclosure?
Roivant Sciences (ROIV) reported investments fair value disclosure of $407.99M in Q1 2026.
How has Roivant Sciences's investments fair value disclosure changed year-over-year?
Roivant Sciences's investments fair value disclosure increased by 34.7% year-over-year, from $302.94M to $407.99M.
What is the long-term trend for Roivant Sciences's investments fair value disclosure?
Over 5 years (2020 to 2025), Roivant Sciences's investments fair value disclosure has grown at a 16.6% compound annual growth rate (CAGR), from $188.98M to $407.99M.